C6022

Cyproheptadine hydrochloride sesquihydrate

≥98% (TLC), solid

• Sinónimos: Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-, hydrochloride, hydrate (2:3)
• Fórmula empírica (notación de Hill): C₂₁H₂₁N·HCl·1.5H₂O
• Número de CAS: 41354-29-4
• Peso molecular: 350.88
• Número CE: 213-535-1
• Número MDL: MFCD00012538
• Código UNSPSC: 12352200
• ID de la sustancia en PubChem: 24278082
• NACRES: NA.77

Propiedades

• Nivel de calidad: 200
• Ensayo: ≥98% (TLC)
• Formulario: solid
• color: white to slightly yellow
• solubilidad: ethanol: soluble; methanol: soluble
• emisor: Merck & Co., Inc., Kenilworth, NJ, U.S.
• cadena SMILES: Cl.CN1CCC(\CC1)=C2/c3ccccc3C=Cc4ccccc24
• InChI: 1S/2C21H21N.2ClH.3H2O/c2*1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21;;;;;/h2*2-11H,12-15H2,1H3;2*1H;3*1H2
• Clave InChI: ZEAUHIZSRUAMQG-UHFFFAOYSA-N
• Información sobre el gen: human ... HRH1(3269) , HTR2A(3356) , HTR2B(3357) , HTR2C(3358)

Descripción

Aplicación

Cyproheptadine hydrochloride sesquihydrate has been used in:

• testing anti-inflammatory activity in serotonin receptor (5-HT) induced inflammation
• the inhibition of 5-HT in in vivo and in vitro bioassays in crabs
• the inhibition of 5-HT in embryo physiological experiments

inhibition of calcitonin gene related peptide (CGRP)

Acciones bioquímicas o fisiológicas

Cyproheptadine hydrochloride sesquihydrate is a serotonin receptor (5-HT2/5-HT1C) antagonist, H1 histamine receptor antagonist and an antipruritic. The inhibition of 5-HT by cyproheptadine improves cognitive function in schizophrenia disorder. Cyproheptadine is effective for treating functional gastrointestinal disorders (FGIDs). Food and Drug Administration (FDA) approved cyproheptadine, has antidepressant and antiplatelet functionality. It may be effective in treating thromboembolic disorders. Cyproheptadine inhibits lysine methyltransferase 7/9 (Set7/9) leading to a decrease in estrogen receptor (ERα) expression and growth arrest in breast cancer cells.

Características y beneficios

This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Información de seguridad

• Pictogramas: GHS06
• Palabra de señalización: Danger
• Frases de peligro: H301,H315,H319,H335
• Consejos de prudencia: P261 - P264 - P271 - P301 + P310 - P302 + P352 - P305 + P351 + P338
• Clasificaciones de peligro: Acute Tox. 3 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• Órganos de actuación: Respiratory system
• Código de clase de almacenamiento: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• Clase de riesgo para el agua (WGK): WGK 3
• Equipo de protección personal: dust mask type N95 (US), Eyeshields, Faceshields, Gloves